Bilateral increase in striatal dopamine D2 receptor density in the 6-hydroxydopamine-lesioned rat: A serial in vivo investigation with small animal PET

European Journal of Nuclear Medicine and Molecular Imaging

Volumn 30, Issue 3, 2003, Pages 390-395

  Nikolaus, Susanne ^a   Larisch, Rolf ^a   Beu, Markus ^a   Forutan, Farhad ^a   Vosberg, Henning ^a   Müller Gärtner, Hans Wilhelm ^a  

^a UNIVERSITY HOSPITAL DÜSSELDORF   (Germany)

Author keywords

6 Hydroxydopamine model; Dopamine D2receptors; Parkinson's disease; Positron emission tomography; 18F N methylbenperidol

Indexed keywords

BENPERIDOL; DOPAMINE 2 RECEPTOR; FLUORINE 18; N METHYLBENPERIDOL F 18; OXIDOPAMINE; RADIOLIGAND; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BINDING SITE; DENERVATION; DIAGNOSTIC IMAGING; DIAGNOSTIC VALUE; DISEASE MODEL; DOPAMINERGIC NERVE CELL; IMAGE ANALYSIS; IMAGE ENHANCEMENT; MALE; NONHUMAN; NONLINEAR REGRESSION ANALYSIS; PARKINSON DISEASE; POSITRON EMISSION TOMOGRAPHY; QUANTITATIVE ANALYSIS; RAT; RECEPTOR BINDING; RECEPTOR DENSITY; REGENERATION; SUBSTANTIA NIGRA; TIME;

EID: 0037532540     PISSN: 16197070     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00259-002-1056-2     Document Type: Article

References (28)

1. Chatziioannou AF. Molecular imaging of small animals with dedicated PET tomographs. Eur J Nucl Med 2002; 29:98-114.
2. Weber S, Bauer A, Herzog H, et al. Recent results of the TierPET scanner. IEEE Trans Nucl Sci 2000; 47:1665-1669.
3. Nikolaus S, Larisch R, Beu M, et al. Imaging of striatal dopamine D2 receptors with a PET system for small laboratory animals in comparison with storage phosphor autoradiography: a validation study with [18F](3-N-methyl)benperidol. J Nucl Med 2001; 42:1691-1696.
4. Nikolaus S, Larisch R, Bier D, et al. In vivo-Messung der striatalen D2-Rezeptordichte und Affinität mit einem Kleintier-PET und [18F] N-Methyl-Benperidol. In: Brink I, Högerle S, Moser E, eds. Nuklearmedizin als Paradigma molekularer Bildgebung. Berlin: Blackwell; 2002:24.
5. Schwarting RKW, Huston JP. Unilateral 6-hydroxydopamine lesions of meso-striatal dopamine neurons and their physiological sequelae. Prog Neurobiol 1996; 49:215-266.
6. Ungerstedt U. Postsynaptic supersensitivity after 6-hydroxydopamine induced degeneration of the nigro-striatal dopamine system. Acta Physiol Scand 1991; 367:69-93.
7. Neve KA, Kozlowski MR, Marshall JF. Plasticity of neostriatal dopamine receptors after nigrostriatal injury: relationship to recovery of sensorimotor functions and behavioral supersensitivity. Brain Res 1982; 244:33-44.
8. Neve KA, Altar CA, Wong CA, et al. Quantitative analysis of [3H]spiroperidol binding to rat forebrain sections: plasticity of neostriatal dopamine receptors after nigrostriatal injury. Brain Res 1984; 302:9-18.
9. Staunton DA, Wolfe BB, Groves PM, Molinoff PB. Dopamine receptor changes following destruction of the nigrostriatal pathway: lack of a relationship to rotational behavior. Brain Res 1981; 211:315-327.
10. Ferré S, Fuxe K. Dopamine denervation leads to an increase in the intramembrane interactions between adenosine A2 and dopamine D2 receptors in the neostriatum. Brain Res 1992; 595:124-130.
11. Hume SP, Opacka-Juffry J, Myers R, et al. Effect of L-dopa and 6-hydroxydopamine lesioning on [11C]raclopride binding in rat striatum quantified using PET. Synapse 1995; 21:45-53.
12. Nguyen TV, Brownell AL, Chen YCI, et al. Detection of the effects of dopamine receptor sensitivity using pharmacological MRI and correlations with PET. Synapse 2000; 36:57-65.
13. Phelps ME. Positron emission tomography provides molecular imaging of biological processes. Proc Natl Acad Sci USA 2000; 97:9226-9233.
14. Paxinos G, Watson C. The rat brain in stereotaxic coordinates. Sydney: Academic Press, 1986.
15. Moerlein SM, Banks WR, Parkinson D. Production of fluorine-18 labeled (3-N-methyl)benperidol for PET investigation of cerebral receptor binding. Appl Radiat Isot 1992; 43:913-917.
16. Beu M, Nikolaus S, Larisch R, Weber S, Vosberg H, MüllerGärtner HW. Ein Algorithmus zur Quantifizierung des Einflusses der Harderschen Drüse auf die striatale Aktivität bei PET-Messungen an der Ratte. Nuklearmedizin 2000; 39:162.
17. Antonini A, Schwarz J, Oertel WH, et al. [11C]raclopride and positron emission tomography in previously untreated patients with Parkinson's disease: influence of L-dopa and lisuride therapy on striatal dopamine D2-receptors. Neurology 1994; 44:1325-1329.
18. Ichise M, Kim YJ, Ballinger JR, et al. SPECT imaging of preand postsynaptic dopaminergic alterations in L-dopa-untreated PD. Neurology 1999; 5:2:1206-1214.
19. Kaasinen V, Ruottinen HM, Nagren K, et al. Upregulation of putaminal dopamine D2 receptors in early Parkinson's disease: a comparative PET study with [11C]raclopride and [11C]methylspiperone. J Nucl Med 2000; 41:65-70.
20. Sawle GV, Playford ED, Brooks DJ, et al. Asymmetrical presynaptic and post-synaptic changes in the striatal dopamine projection in dopa naive parkinsonism: diagnostic implications of the D2 receptor status. Brain 1993; 116:853-867.
21. Mishra RK, Marshall AM, Varmuza SL. Supersensitivity in rat caudate nucleus: effects of 6-hydroxydopamine on the time course of dopamine receptor and cyclic AMP changes. Brain Res 1980; 200:47-57.
22. Narang N, Wamsley JK. Time dependent changes in DA uptake sites, D1 and D2 receptor binding and mRNA after 6-OHDA lesions of the medial forebrain bundle in the rat brain. J Chem Neuroanat 1995; 9:41-53.
23. Chalon S, Edmond P, Bodard S, et al. Time course of changes in striatal dopamine transporters and D2 receptors with specific iodinated markersin a rat model of Parkinson's disease. Synapse 1999; 31:134-139.
24. Guerin B, Silice C, Mouchet P, Feuerstein C, Demenge P. Changes of the striatal 3H-spiperone binding 3-6 weeks after nigrostriatal denervation and after two years. Life Sci 1985; 37:953-961.
25. Pan HS, Penney JB, Young AB. Gamma-aminobutyric acid and benzodiazepine receptor changes induced by unilateral 6-hydroxydopamine lesions of the medial forebrain bundle. J Neurochem 1985; 45:1396-1404.
26. Feuerstein C, Demenge P, Caron P, Barrette G, Guerin B, Mouchet P. Supersensitivity time course of dopamine antagonist binding after nigrostriatal denervation: evidence for early and drastic changes in the rat corpus striatum. Brain Res 1981; 226:221-234.
27. Nikolaus S, Huston JP, Körber B, Thiel C, Schwarting RKW. Pretreatment with neurokinin substance P but not with cholecystokinin-8S can alleviate functional deficits of partial nigrostriatal 6-hydroxydopamine lesion. Peptides 1997; 18:1161- 1168.
28. Pritzel M, Huston JP, Sarter M. Behavioral and neuronal reorganization after unilateral substantia nigra lesions: evidence for increased interhemispheric nigrostriatal projections. Neuroscience 1983; 9:879-888.